Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of cytotoxic T lymphocytes ...

Replimune Group Inc (NASDAQ: NASDAQ:REPL), a biotech firm focused on oncolytic immunotherapies, announced today that its Biologics License Application (BLA) for RP1 in combination with nivolumab has ...

WEST CHESTER, Pa. - Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), a small-cap pharmaceutical company ($61.34M market cap) ...

The American Cancer Society's latest cancer report shows both positive and concerning trends: overall cancer deaths are down ... called for more screening and treatment options.

The new American Cancer Society report indicates a troubling increase in cancer diagnoses among younger people, with women, especially younger ones, facing higher cancer rates and mortality.

"Continued reductions in cancer mortality because of drops in smoking, better treatment and earlier detection is certainly great news," Rebecca Siegel, senior scientific director of surveillance ...

Working-age women in the US are now more likely to get cancer than men of the same age. A new report out Thursday from the American Cancer Society showed that the number of women under 65 ...

(WXYZ) — A new report shows big changes in cancer trends across the U.S. While cancer deaths have dropped overall, more women and younger adults are being diagnosed ...